Navigation Links
Psychiatric Drugs Might Raise Cardiac Death Risk
Date:5/14/2009

But other medical factors could also be at play, researchers note

THURSDAY, May 14 (HealthDay News) -- Preliminary research suggests people who suffered fatal cardiac arrest were more likely to have taken antidepressants and other psychiatric drugs than those who survived heart attacks.

But the findings haven't been confirmed elsewhere, and it's not clear whether the medications directly cause any problems. Those who take the drugs could have other medical issues that contribute to a higher death rate, the researchers noted.

"It is too early to give concrete advice" to patients who take the drugs, said study author Dr. Jussi Honkola, a researcher at the University of Oulu in Finland. "We need further studies about this possible relationship."

In other words, there's no indication that anyone needs to change the drugs that they take for conditions such as depression and anxiety.

At issue is sudden cardiac death -- when someone dies suddenly and unexpectedly, often within minutes, after the heart stops functioning properly. Heart attacks can lead to cardiac arrest and then sudden cardiac death. But heart attacks are technically something else -- the death of heart tissue because blood flow is disrupted.

A variety of conditions can cause sudden cardiac death, including the clogging of arteries caused by coronary heart disease.

And, "despite many years of intensive research we still don't know how to identify people who are at risk for sudden cardiac death," Honkola said.

In the new study, the Finnish researchers examined the medications taken by 321 victims of cardiac death compared with those taken by 609 patients who survived heart attacks.

The findings were to be released Thursday at the Heart Rhythm Society's annual meeting, in Boston.

The study doesn't reveal specifically which psychiatric drugs were examined, but it does say that those who died of cardiac death were more likely to have taken one of three types.

Almost 11 percent of those who suffered sudden cardiac death took antipsychotics, compared to 1.4 percent of those who survived heart attacks. The numbers for antidepressants were 7.4 percent and 3 percent, respectively, and 18.4 percent and 5 percent for benzodiazepines, which include drugs such as Xanax.

Those who survived heart attacks were more likely to take aspirin and the heart drugs known as beta blockers.

The findings "are interesting, even provocative, but much more work remains to be done in order to have a high degree of confidence in the results," said Dr. Robert A. Harrington, director of the Duke Clinical Research Institute in Durham, N.C.

"For now, society should insist upon randomized clinical trials during and after the drug approval process that test therapies in patients who will likely take the drugs in 'real life,'" Harrington said.

That means those who take part in tests of drugs represent those who ultimately take them when it comes to their medical conditions and the other drugs that they're taking, he explained.

More information

Learn more about sudden cardiac death from the American Heart Association.



SOURCES: Jussi Honkola, M.D., researcher, University of Oulu, Finland; Robert A. Harrington, M.D., professor, medicine, Division of Cardiology, and director, Duke Clinical Research Institute, Durham, N.C.; May 14, 2009, presentation, Heart Rhythm Society annual meeting, Boston


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Oncologists are critical in managing psychiatric disorders in patients with advanced cancer
2. Salugen to Present Research on Generational Associations of Reward Deficiency Syndrome at XVth World Congress on Psychiatric Genetics
3. American Psychiatric Foundation Hosts a Benefit for New Orleans Mental Health Organizations as a Part of the Institute for Psychiatric Services Conference
4. Psychiatric Woes Can Postpone Weight-Loss Surgery
5. NARSAD - the Worlds Leading Mental Health Research Charity - Presents 2007 Prizes for Outstanding Psychiatric Research at New York Gala, October 19th
6. Services for patients with BPD need to be improved say psychiatric nurses
7. Shire to Present New Scientific Data on its ADHD Treatments at a Major Psychiatric Meeting
8. Psychiatrists, parents significantly differ in ADHD, psychiatric comorbidities perceptions
9. Child mental health experts issue psychiatric medication treatment guidelines for preschoolers
10. Treating patients with psychiatric disorders for hepatitis C
11. Relatives of Parkinsons Patients at Higher Psychiatric Risk
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Psychiatric Drugs Might Raise Cardiac Death Risk
(Date:4/26/2017)... ... April 26, 2017 , ... Bioclinica® ... sponsors and CROs to speed clinical development, has released the industry’s only ... Bioclinica AGILE RTSM provides seamless clinical supply forecasting and management together ...
(Date:4/25/2017)... KY (PRWEB) , ... April 25, 2017 , ... ... announce they have signed an agreement to be the preferred physical therapy provider ... injuries and returning them to Derby City CrossFit as quickly and effectively as ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from the ... for the 2015-16 school year across Wisconsin’s public schools, charter schools, and private ... patterns in student test score performance, the report’s limited analyses fail to provide ...
(Date:4/25/2017)... ... 2017 , ... As pharmaceutical companies are held to increasingly ... innovation in drug formulation and manufacturing. CoreRx offers its clients more than ... support of their development and manufacturing goals. , The company was created ...
(Date:4/25/2017)... Scotch Plains, NJ (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD ... with the treatment of acute or chronic problems, I focus on preventative care with all ... patient. If you have any questions, always feel free to contact my office and my ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology: